In contrast, mice receiving eTc-IL10 injection in the CM had a significant improvement of functional outcome at 48 hr after stroke as shown by a reduced forelimb asymmetry in comparison to vehicle-treated mice (Figure 4E). The gene discussed is IL10; the disease is stroke disorder.